Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Riley

Showing results (101-110 of 127) with videos related to

Pageof 13
Sort By:
Cancer Research|February 23, 2021
NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant TransformationJan M Pawlicki, David L Cookmeyer, Damian Maseda, et al.
Science Translational Medicine|May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsJohn Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
Cytotherapy|November 27, 2016
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trialsDavid H McKenna, Darin Sumstad, Diane M Kadidlo, et al.
Nature Medicine|September 2, 2020
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivoColby R Maldini, Daniel T Claiborne, Ken Okawa, et al.
Plos Pathogens|October 13, 2017
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptorRachel S Leibman, Max W Richardson, Christoph T Ellebrecht, et al.
Blood|July 3, 2020
Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primatesBlake J Rust, Leslie S Kean, Lucrezia Colonna, et al.
Blood|July 23, 2008
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cellsKeli L Hippen, Paul Harker-Murray, Stephen B Porter, et al.
Blood|February 24, 2026
Antigen-boosted CD4 CAR-T cells fail to expand or control viremia in multiple nonhuman primate models of HIVLucy Maynard, Carly E Starke, Nikhita Hegde Poole, et al.
Pageof 13

Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Cancer Research|February 23, 2021
NPM-ALK-Induced Reprogramming of Mature TCR-Stimulated T Cells Results in Dedifferentiation and Malignant TransformationJan M Pawlicki, David L Cookmeyer, Damian Maseda, et al.
Science Translational Medicine|May 4, 2012
Decade-long safety and function of retroviral-modified chimeric antigen receptor T cellsJohn Scholler, Troy L Brady, Gwendolyn Binder-Scholl, et al.
Science Translational Medicine|May 18, 2012
CD25 blockade depletes and selectively reprograms regulatory T cells in concert with immunotherapy in cancer patientsAndrew J Rech, Rosemarie Mick, Sunil Martin, et al.
Science Translational Medicine|May 20, 2011
Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activityKeli L Hippen, Sarah C Merkel, Dawn K Schirm, et al.
Cytotherapy|November 27, 2016
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trialsDavid H McKenna, Darin Sumstad, Diane M Kadidlo, et al.
Nature Medicine|September 2, 2020
Dual CD4-based CAR T cells with distinct costimulatory domains mitigate HIV pathogenesis in vivoColby R Maldini, Daniel T Claiborne, Ken Okawa, et al.
Plos Pathogens|October 13, 2017
Supraphysiologic control over HIV-1 replication mediated by CD8 T cells expressing a re-engineered CD4-based chimeric antigen receptorRachel S Leibman, Max W Richardson, Christoph T Ellebrecht, et al.
Blood|July 3, 2020
Robust expansion of HIV CAR T cells following antigen boosting in ART-suppressed nonhuman primatesBlake J Rust, Leslie S Kean, Lucrezia Colonna, et al.
Blood|July 23, 2008
Umbilical cord blood regulatory T-cell expansion and functional effects of tumor necrosis factor receptor family members OX40 and 4-1BB expressed on artificial antigen-presenting cellsKeli L Hippen, Paul Harker-Murray, Stephen B Porter, et al.
Blood|February 24, 2026
Antigen-boosted CD4 CAR-T cells fail to expand or control viremia in multiple nonhuman primate models of HIVLucy Maynard, Carly E Starke, Nikhita Hegde Poole, et al.
Pageof 13